Eli Lilly Corp. buy SVB Leerink LLC
Start price
10.11.25
/
50%
€807.50
Target price
10.11.26
€955.18
Performance (%)
12.94%
Price
09:43
€912.00
Summary
This prediction is currently active. The prediction currently has a performance of 12.94%. This prediction currently runs until 10.11.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | 5.401% | 5.401% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $1,104.00 price target on the stock, up previously from $886.00.
Ratings data for LLY provided by MarketBeat